
Privacy notice | Accessibility statement | Terms and conditions | Login | Contact |
UK data driving real-world evidence
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 6 April 2021) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 5MB, 226 pages)This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website.
“A population-based study examining the risk of malignancy in patients diagnosed with inflammatory bowel disease”, J Gastroenterol, vol. 51, pp. 1050-1062, 2016.
, “A population-based study of appetite-suppressant drugs and the risk of cardiac-valve regurgitation”, N Engl J Med, vol. 339, pp. 719-24, 1998.
, “Population-Based Study on the Epidemiology of Meniere's Disease”, Audiol Neurootol, vol. 22, pp. 74-82, 2017.
, “The Potential of Glycemic Control and Body Weight Change as Early Markers for Pancreatic Cancer in Patients With Long-standing Diabetes Mellitus: A Case-Control Study”, PancreasPancreasPancreas, vol. 47, pp. 807-815, 2018.
, “Pregnancies and terminations after 1995 warning about third-generation oral contraceptives”, Lancet, vol. 351, pp. 1404-5, 1998.
, “Previously diagnosed influenza infections and the risk of developing epilepsy”, Epidemiol Infect, vol. 143, pp. 2408-15, 2015.
, “Proton Pump Inhibitor Use and Risk of Developing Alzheimer's Disease or Vascular Dementia: A Case-Control Analysis”, Drug Saf, vol. 41, pp. 1387-1396, 2018.
, “Psoriasis and risk of incident cancer: an inception cohort study with a nested case-control analysis”, J Invest Dermatol, vol. 129, pp. 2604-12, 2009.
, “Psoriasis and risk of incident myocardial infarction, stroke or transient ischaemic attack: an inception cohort study with a nested case-control analysis”, Br J Dermatol, vol. 160, pp. 1048-56, 2009.
, “Psoriasis and the risk of incident diabetes mellitus: a population-based study”, Br J Dermatol, vol. 159, pp. 1331-7, 2008.
, “Quality and completeness of diagnoses recorded in the new CPRD Aurum Database: evaluation of pulmonary embolism”, Pharmacoepidemiol Drug Saf, 2020.
, “Rates of Cancers and Opportunistic Infections in Patients With Psoriatic Arthritis Compared With Patients Without Psoriatic Arthritis”, J Clin Rheumatol, vol. 22, pp. 241-7, 2016.
, “Recent use of oral contraceptives and the risk of multiple sclerosis”, Arch Neurol, vol. 62, pp. 1362-5, 2005.
, “Recombinant hepatitis B vaccine and the risk of multiple sclerosis: a prospective study”, Neurology, vol. 63, pp. 838-42, 2004.
, “Reflux disease, gastrointestinal ulcer or weight loss in patients with COPD”, Copd, vol. 7, pp. 172-8, 2010.
, “Risk for incident atrial fibrillation in patients who receive antihypertensive drugs: a nested case-control study”, Ann Intern Med, vol. 152, pp. 78-84, 2010.
, “The Risk of Achilles or Biceps Tendon Rupture in New Statin Users: A Propensity Score-Matched Sequential Cohort Study”, Drug Saf, vol. 39, pp. 1229-1237, 2016.
, “The risk of adverse outcomes in association with use of testosterone products: a cohort study using the UK-based general practice research database”, Br J Clin Pharmacol, vol. 75, pp. 260-70, 2013.
, “Risk of cardiovascular outcomes in users of estradiol/dydrogesterone or other HRT preparations”, Climacteric, vol. 12, pp. 445-53, 2009.
, “The risk of cataract among users of inhaled steroids”, Epidemiology, vol. 12, pp. 229-34, 2001.
, “Risk of cholestatic liver disease associated with flucloxacillin and flucloxacillin prescribing habits in the UK: cohort study using data from the UK General Practice Research Database”, Br J Clin Pharmacol, vol. 60, pp. 76-82, 2005.
, “Risk of colorectal cancer after initiation of orlistat: matched cohort study”, Bmj, vol. 347, p. f5039, 2013.
, “Risk of erectile dysfunction associated with use of 5-alpha reductase inhibitors for benign prostatic hyperplasia or alopecia: population based studies using the Clinical Practice Research Datalink”, Bmj, vol. 354, p. i4823, 2016.
, “The risk of gastrointestinal bleed, myocardial infarction, and newly diagnosed hypertension in users of meloxicam, diclofenac, naproxen, and piroxicam”, Pharmacotherapy, vol. 20, pp. 741-4, 2000.
, “Risk of gynecological cancers in users of estradiol/dydrogesterone or other HRT preparations”, Climacteric, vol. 12, pp. 514-24, 2009.
, “Risk of gynecomastia and breast cancer associated with the use of 5-alpha reductase inhibitors for benign prostatic hyperplasia”, Clin Epidemiol, vol. 9, pp. 83-91, 2017.
, “Risk of hand osteoarthritis in new users of hormone replacement therapy: A nested case-control analysis”, Maturitas, vol. 132, pp. 17-23, 2020.
, “Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components”, Lancet, vol. 346, pp. 1589-93, 1995.
, “Risk of idiopathic cerebral haemorrhage in women on oral contraceptives with differing progestagen components”, Lancet, vol. 354, pp. 302-3, 1999.
, “Risk of Incident Antidepressant-Treated Depression Associated with Use of 5alpha-Reductase Inhibitors Compared with Use of alpha-Blockers in Men with Benign Prostatic Hyperplasia: A Population-Based Study Using the Clinical Practice Research Datalink”, Pharmacotherapy, vol. 37, pp. 517-527, 2017.
, “Risk of incident depression in patients with Parkinson disease in the UK”, Eur J Neurol, vol. 18, pp. 448-53, 2011.
, “Risk of Incident Osteoarthritis of the Hand in Statin Initiators: A Sequential Cohort Study”, Arthritis Care Res (Hoboken), vol. 70, pp. 1795-1805, 2018.
, “Risk of incident stroke in patients with Alzheimer disease or vascular dementia”, Neurology, vol. 81, pp. 910-9, 2013.
, “The Risk of Muscular Events Among New Users of Hydrophilic and Lipophilic Statins: an Observational Cohort Study”, J Gen Intern Med, 2021.
, “The risk of new onset depression in association with influenza–A population-based observational study”, Brain Behav Immun, vol. 53, pp. 131-137, 2016.
, “The risk of newly diagnosed asthma in migraineurs with or without previous triptan prescriptions”, Headache, vol. 48, pp. 606-10, 2008.
, “Risk of Seizures Associated with Antidepressant Use in Patients with Depressive Disorder: Follow-up Study with a Nested Case-Control Analysis Using the Clinical Practice Research Datalink”, Drug Saf, vol. 39, pp. 307-21, 2016.
, “The risk of severe depression, psychosis or panic attacks with prophylactic antimalarials”, Drug Saf, vol. 27, pp. 203-13, 2004.
, “Risk of skin cancer in new users of thiazides and thiazide-like diuretics: a cohort study using an active comparator group”, Br J Dermatol, 2021.
, “The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptic drugs”, Epilepsia, vol. 58, pp. 2178-2185, 2017.
, “Risk of stroke in patients with idiopathic Parkinson disease”, Parkinsonism Relat Disord, vol. 16, pp. 31-5, 2010.
, “The risk of unintended pregnancies in users of the contraceptive patch compared to users of oral contraceptives in the UK General Practice Research Database”, Contraception, vol. 80, pp. 142-51, 2009.
, “Risk of venous thromboembolism among users of third generation oral contraceptives compared with users of oral contraceptives with levonorgestrel before and after 1995: cohort and case-control analysis”, Bmj, vol. 321, pp. 1190-5, 2000.
, “Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database”, Bmj, vol. 342, p. d2139, 2011.
, “The risk of venous thromboembolism in users of postcoital contraceptive pills”, Contraception, vol. 59, pp. 79-83, 1999.
, “Rosacea in Patients with Ulcerative Colitis and Crohn's Disease: A Population-based Case-control Study”, Inflamm Bowel Dis, vol. 22, pp. 680-7, 2016.
, “Rosiglitazone use and post-discontinuation glycaemic control in two European countries, 2000-2010”, BMJ Open, vol. 3, p. e003424, 2013.
, “Seizures in patients with Alzheimer's disease or vascular dementia: a population-based nested case-control analysis”, Epilepsia, vol. 54, pp. 700-7, 2013.
, “Selective Serotonin Reuptake Inhibitors and Cataract Risk: A Case-Control Analysis”, Ophthalmology, vol. 124, pp. 1635-1639, 2017.
, “Serious adverse effects associated with glucocorticoid therapy in patients with giant cell arteritis (GCA): A nested case-control analysis”, Semin Arthritis Rheum, vol. 46, pp. 819-827, 2017.
,